Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma

Published:2024-01-24 Issue:6 Volume:16 Page:405-426
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Jani Yash¹^ORCID,Jansen Caroline S²³^ORCID,Gerke Margo B²^ORCID,Bilen Mehmet Asim³⁴

Affiliation:

1. Mercer University, Macon, GA31207, USA

2. Emory University School of Medicine, Atlanta, GA30322, USA

3. Winship Cancer Institute of Emory University, Atlanta, GA30322, USA

4. Department of Hematology & Medical Oncology, Emory University School of Medicine, Atlanta, GA30322, USA

Funder

National Cancer Institute

Medical Scientist Training Program

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/imt-2023-0267

Reference168 articles.

1. Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma

2. Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

3. Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis

4. Resistance to targeted therapy in renal-cell carcinoma

5. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP